$ALNY #ALNY looks interesting Buy at $140 ? Any thoughts?$simple $enough $fun
$ALNY #ALNY looks interesting Buy at $140 ? Any thoughts?
I have no position yet.
0HD2 trade ideas
Head and ShouldersIf price falls below neckline, possibe fall to lower levels..Pattern not valid until price goes below neckline or $120..I colored the neckline red vs green because this is a bearish pattern, but the line is support. If price does not fall below support, this pattern can change.
Targets if falls below neckline: 90.8 83 Targets 2: 60 43.5
Possible stop above 134.35.
The head and shoulders chart pattern is a popular and easy to spot pattern in technical analysis that shows a baseline with three peaks, the middle peak being the highest. The head and shoulders chart depicts a bullish-to-bearish trend reversal and signals that an upward trend is nearing its end.
The initial peak and subsequent decline represent the waning momentum of the prior bullish trend. Wanting to sustain the upward movement as long as possible, bulls rally to push the price back up past the initial peak to reach a new high (the head). At this point, it is still possible that bulls could reinstate their market dominance and continue the upward trend.
However, once price declines a second time and reaches a point below the initial peak, it is clear that bears are gaining ground. Bulls try one more time to push price upward but succeed only in hitting the lesser high reached in the initial peak. This failure to surpass the highest high signals the bulls' defeat and bears take over, driving the price downward and completing the reversal
Not a recommendation
ALNY getting near support level$120 has been a solid support level for some time now. I'm hoping to buy at $121 and ride it up when it bounces.
My stop loss will be pretty tight at around $118.
I think my target will be $132.
RSI is also about to hit oversold levels.
The only thing that worries me is that the whole chart has made a head and shoulders pattern. Also, the market has not been happy these past few days.
ALNY surges on Blackrock $2 billion investmentShares of Alnylam Pharmaceuticals Inc. ALNY, +4.48% rallied 7.4% in premarket trading Monday, after Blackstone Group Inc. BX, +4.68% confirmed that it was investing $2 billion in the biopharmaceutical company. The deal was earlier reported by The Wall Street Journal. The investment includes $1 billion to buy 50% of the royalties and commercial milestones of Alnylam's high cholesterol treatment inclisiran, and up to $150 million to develop Alnylam's cardiometabolic programs vutrisiran and ALN-AGT. Blackstone will also provide Alnylam with a term loan of up to $750 million and is buying $100 million worth of newly issued stock. Alnylam's stock has gained 1.5% over the past three months through Friday, while Blackstone shares have lost 15.9% and the S&P 500 SPX, +1.44% has declined 15.2%.
Source MarketWatch
